The Au-HN-1 nanosystem represents a breakthrough in TSCC treatment, integrating targeted photothermal therapy with advanced ...

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...

Cell penetrating peptides expand pivotal roles in oncology, neurology, and immunotherapy, connecting specialized carriers ...

Given the encouraging results, the Company has decided to expand on its therapeutic mRNA research and development program. “We are pleased with the initial in vivo efficacy results of our first ...

However, questions remain regarding the potential role for natriuretic peptides to guide therapy in patients with HF. In this Review, we address the underlying assumptions and the existing ...

Journal of Nuclear Medicine January 2025, jnumed.124.268861; DOI: https://doi.org/10.2967/jnumed.124.268861 ...

1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut. 2Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.

The most common method for creating an amide bond is the use of carbodiimide condensing agents such as dicyclohexylcarbodiimide and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride. The ...

Why have the previous anti-tau therapies shown limited efficacy in vivo ... the therapeutic antibodies can cause serious side effects. Before I joined the group, the Eisenberg team used tau’s ...

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.biomac.4c01189. The effect of the cross-linker on the grafting ...